Healthy Q1 earnings drive Advanced Enzyme on D-Street; stock gains 9% in 2 days

The company recorded a standalone net profit of Rs15.32cr in Q1, rising by 15.42% compared to Rs13.27cr a year ago same period.

Aug 14, 2020 04:08 IST India Infoline News Service

Advanced Enzymes
Advanced Enzyme has witnessed consecutive upside after its financial performance announcement for the first quarter ending June 2020 (Q1FY21) period. The company recorded a standalone net profit of Rs15.32cr in Q1, rising by 15.42% compared to Rs13.27cr a year ago same period. While standalone net sales jumped by 4.94% to Rs61.41cr against Rs58.51cr of the similar quarter last year.

Consolidated key highlights of Q1FY21 are:
  • Consolidated Q1FY21 Sales up 0.1% yoy to Rs110.5cr against Rs110.3cr in Q1FY20
  • Consolidated EBITDA for Q1FY21 stands at Rs51.7cr against Rs53.5cr in Q1FY20, down 3.3%
  • Consolidated EBITDA Margin for Q1FY21 stands at 47% as against 48% in Q1FY20
  • Consolidated Q1FY21 Net Profit rise by 3% at Rs34.8cr against Rs34cr in Q1FY20
The Q1 performance was presented on August 12, where the company's stock ending at Rs208.8 per piece level.

In last two-consecutive trading days, the stock has gained by as much as 8.9% as it clocked an intraday high of Rs227.40 per piece on Sensex during Friday's session.

The stock ended at Rs216.85 per piece up 4.30% on the same index.

Related Story